Screnci D, McKeage MJ. Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches. J Inorg Biochem 1999;77:105-10. Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, LiebermanF. Diagnosis, managementand evaluation of chemotherapy induced peripheral neuropathy. Sem Oncol 2006;33(1);15-49. Antoine JC, Camdessanché JP. Peripheral nervous system involvement in patients with cancer. Lancet Neurol.2007;6:75-86. KrishnanAV.Oxaliplatin-induced neurotoxicity and the development of neuropathy.Muscle Nerve 2005;32(1):51-60. R. Velasco y J. Bruna. Neuropatía inducida por quimioterapia: un problema no resuelto. Neurología. 2010;25(2):116-131 Albers J, Chaudhry V, Cavaletti G, Donehower R. Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev. 2007 Jan 24;(1): CD005228. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemo¬therapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer. 2008; 44:1507-15. Kaley TJ, Deangelis LM. Therapy of chemotherapy-induced peripheral neuropathy. Br J Haematol. 2009; 145:3-14. Albers J, Chaudhry V, Cavaletti G, Donehower R. Intervenciones para la prevención de la neuropatía por cisplatino y compuestos relacionados (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 2. Oxford: Update Software Ltd. Pace A, Savarese A, Picardo M, Maresca V, Pacetti U, Del Monte G, et al. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. JClin Oncol 2003;21(5):927-31. Argyriou AA, et al. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results. Support Care Cancer. 2006;14(11):1134-40. Argyriou AA, Chroni E, Koutras A, Iconomou G, Papapetropoulos S, Polychronopoulos P, et al. Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation. J Pain Symptom Manage 2006; 32(3):237-44. Pace A, Giannarelli D, Galiè E, Savarese A, Carpano S, Della Giulia M, et al. Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo controlled trial. Neurology 2010; 74(9):762-6. Samuel Oliveira ,et al. Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial. Sao Paulo Med. J. vol.131 no.1 2013 Ma H, Das T, Pereira S, Yang Z, Zhao M, Mukerji P, Hoffman RP. Anticancer Res 2009; 29: 2421-2416. James G. Kalkanis,et al. Vitamin E Reduces Cisplatin Ototoxicity. Article first published online: 3 JAN 2009, D. Appenroth,et al. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. June 1997 Michael Benatar. Evidence and analysis in clinical neurology. Neuromuscular disease. Part III. Peripheral nerve disease. Humana Press Inc. Totowa, New Jersey. 2006.